Delivery Order SPE2DB22D1106-SPE2DB25FFCE7
- Not listed
- The Defense Logistics Agency (DLA) awarded a $2,665.50 delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs, with a completion date of July 30, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on August 4, 2025, with a ceiling value of $2,652.31 and an ultimate completion date of August 5, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The...
- The Defense Logistics Agency awarded a $2,273.86 delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs on August 7, 2025, with completion expected by August 8, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a procurement of critical emergency medical supplies for federal...
- The Defense Logistics Agency awarded a delivery order valued at $17,703.31 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,376.29. This is a firm fixed-price delivery order with no set-aside designation, placed under competitive procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $4,883.60 and an ultimate completion date of July 30, 2025. This delivery order represents a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,856.40 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, firm fixed-price contract was executed on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a child order under a larger contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency (DLA) awarded a $1,292.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2-pack) on August 4, 2025, with an ultimate completion date of August 5, 2025. This non-set-aside contract represents a routine pharmaceutical procurement supporting federal medical supply requirements. The award was placed of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract value of $3,545.04. The award was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a firm fixed-price delivery order with no set-aside designation. The contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFCE7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector kits (two-pack) on August 8, 2025, with a ceiling value of $2,320.50 and an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's substantial federal contract portfolio demonstrates its capability to meet DLA requirements across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard through flexible contract mechanisms designed to support the military's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/8/25 |